These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
105 related items for PubMed ID: 8370917
1. Effect of the enhancement of the cholinergic tone by pyridostigmine on the exercise-induced growth hormone release in man. Cappa M, Grossi A, Benedetti S, Drago F, Loche S, Ghigo E. J Endocrinol Invest; 1993 Jun; 16(6):421-4. PubMed ID: 8370917 [Abstract] [Full Text] [Related]
2. Growth hormone secretion in aging. Effect of pyridostigmine on growth hormone responsiveness to growth hormone-releasing hormone. Giusti M, Marini G, Sessarego P, Peluffo F, Valenti S, Caratti C, Giordano G. Recenti Prog Med; 1991 Dec; 82(12):665-8. PubMed ID: 1815302 [Abstract] [Full Text] [Related]
6. Activation of cholinergic tone by pyridostigmine reverses the inhibitory effect of corticotropin-releasing hormone on the growth hormone-releasing hormone-induced growth hormone secretion. Corsello SM, Tofani A, Della Casa S, Sciuto R, Rota CA, Colasanti S, Bini A, Barini A, Barbarino A. Acta Endocrinol (Copenh); 1992 Feb; 126(2):113-6. PubMed ID: 1543015 [Abstract] [Full Text] [Related]
8. Pyridostigmine potentiates growth hormone (GH)-releasing hormone-induced GH release in both men and women. Arvat E, Cappa M, Casanueva FF, Dieguez C, Ghigo E, Nicolosi M, Valcavi R, Zini M. J Clin Endocrinol Metab; 1993 Feb; 76(2):374-7. PubMed ID: 8432781 [Abstract] [Full Text] [Related]
9. Pyridostigmine blocks the inhibitory effect of glucocorticoids on growth hormone-releasing hormone stimulated growth hormone secretion in normal man. Giustina A, Girelli A, Doga M, Bodini C, Bossoni S, Romanelli G, Wehrenberg WB. J Clin Endocrinol Metab; 1990 Sep; 71(3):580-4. PubMed ID: 2118535 [Abstract] [Full Text] [Related]
11. Pyridostigmine potentiates L-dopa- but not arginine- and galanin-induced growth hormone secretion in children. Ghigo E, Bellone J, Imperiale E, Arvat E, Mazza E, Valetto MR, Boffano GM, Cappa M, Loche S, De Sanctis C. Neuroendocrinology; 1990 Jul; 52(1):42-5. PubMed ID: 1697660 [Abstract] [Full Text] [Related]
12. Complete inhibition of hypothalamic somatostatin activity is only partially responsible for the growth hormone response to strenuous exercise. de Vries WR, Abdesselam SA, Schers TJ, Maas HC, Osman-Dualeh M, Maitimu I, Koppeschaar HP. Metabolism; 2002 Sep; 51(9):1093-6. PubMed ID: 12200751 [Abstract] [Full Text] [Related]
13. Influence of endogenous cholinergic tone and growth hormone-releasing peptide-6 on exercise induced growth hormone release. Nooitgedagt A, Koppeschaar HP, de Vries WR, Sidorowicz A, Klok LJ, Dieguez C, Mallo F. Clin Endocrinol (Oxf); 1997 Feb; 46(2):195-202. PubMed ID: 9135702 [Abstract] [Full Text] [Related]
14. Evidence against depletion of the growth hormone (GH)-releasable pool in human primary hypothyroidism: studies with GH-releasing hormone, pyridostigmine, and arginine. Valcavi R, Valente F, Dieguez C, Zini M, Procopio M, Portioli I, Ghigo E. J Clin Endocrinol Metab; 1993 Sep; 77(3):616-20. PubMed ID: 8103770 [Abstract] [Full Text] [Related]
15. Different effects of pyridostigmine on growth hormone (GH) response to GH-releasing hormone in endogenous and exogenous hypercortisolemic patients. Borges MH, Castro RC, Kater CE, Lengyel AM. Braz J Med Biol Res; 1993 Nov; 26(11):1191-200. PubMed ID: 7907904 [Abstract] [Full Text] [Related]
16. Evidence that alpha 2-adrenergic pathways play a major role in growth hormone (GH) neuroregulation: alpha 2-adrenergic agonism counteracts the inhibitory effect of muscarinic cholinergic receptor blockade on the GH response to GH-releasing hormone, while alpha 2-adrenergic blockade diminishes the potentiating effect of increased cholinergic tone on such stimulation in normal men. Devesa J, Diaz MJ, Tresguerres JA, Arce V, Lima L. J Clin Endocrinol Metab; 1991 Aug; 73(2):251-6. PubMed ID: 1677361 [Abstract] [Full Text] [Related]
17. Glucocorticoids may inhibit growth hormone release by enhancing beta-adrenergic responsiveness in hypothalamic somatostatin neurons. Lima L, Arce V, Diaz MJ, Tresguerres JA, Devesa J. J Clin Endocrinol Metab; 1993 Feb; 76(2):439-44. PubMed ID: 8094392 [Abstract] [Full Text] [Related]
18. Acute administration of pyridostigmine and clonidine has an additive stimulatory effect on GH release in normal children. Ghigo E, Goffi S, Mazza E, Imperiale E, Arvat E, Bellone J, Procopio M, Müller EE, Camanni F. J Endocrinol Invest; 1989 Feb; 12(2):99-101. PubMed ID: 2754188 [Abstract] [Full Text] [Related]
19. Massive growth hormone (GH) discharge in obese subjects after the combined administration of GH-releasing hormone and GHRP-6: evidence for a marked somatotroph secretory capability in obesity. Cordido F, Peñalva A, Dieguez C, Casanueva FF. J Clin Endocrinol Metab; 1993 Apr; 76(4):819-23. PubMed ID: 8473389 [Abstract] [Full Text] [Related]
20. Acipimox-mediated plasma free fatty acid depression per se stimulates growth hormone (GH) secretion in normal subjects and potentiates the response to other GH-releasing stimuli. Peino R, Cordido F, Peñalva A, Alvarez CV, Dieguez C, Casanueva FF. J Clin Endocrinol Metab; 1996 Mar; 81(3):909-13. PubMed ID: 8772549 [Abstract] [Full Text] [Related] Page: [Next] [New Search]